Advanced Biomed Inc. Common Stock (ADVB)
ADVBPrice: $5.45
Fair Value: 🔒
🔒score
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, a fully automated sample preparation system that enable... more
Advanced Biomed Inc., an investment holding company, engages in the research and development of micr... more
Description
Shares
| Market Cap | $5.90M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Yi Lu |
| IPO Date | 2025-03-06 | CAGR | — |
| Employees | 40 | Website | www.advanbiomed.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ADVB chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.31M | P/E Ratio | 1.55 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 521762327297268.75 | P/B Ratio | 521762327297268.75 |
| P/CF Ratio | -521762327297268.75 | P/FCF Ratio | -521762327297268.75 |
| EPS | $3.52 | EPS Growth 1Y | 1.49% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | inf% | Gross Margin | -0.44% |
| Operating Margin | -80.9% | Profit Margin | -157.06% |
| ROE | -1.37% | ROA | -0.43% |
| ROCE | -0.44% | Current Ratio | 1.92 |
| Quick Ratio | 1.92 | Cash Ratio | 0.87 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | -3.54 | Piotroski Score | 4 |